KYORIN Pharmaceutical Co., Ltd. (TYO:4569)
Japan · Delayed Price · Currency is JPY 1,681.00
+10.00 (0.60%)
At close: Mar 27, 2026
KYORIN Pharmaceutical Market Cap
KYORIN Pharmaceutical has a market cap or net worth of 96.57 billion as of March 27, 2026. Its market cap has increased by 22.07% in one year.
Market Cap
96.57B
Enterprise Value
108.14B
Revenue
133.26B
Ranking
n/a
PE Ratio
8.97
Stock Price
1,681.00
Market Cap Chart
Since March 10, 2006, KYORIN Pharmaceutical's market cap has increased from 18.24B to 96.57B, an increase of 429.30%. That is a compound annual growth rate of 8.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 96.57B | 9.36% |
| Dec 30, 2025 | 88.30B | 2.13% |
| Dec 30, 2024 | 86.46B | -15.45% |
| Dec 29, 2023 | 102.26B | 3.75% |
| Dec 30, 2022 | 98.56B | -6.82% |
| Dec 30, 2021 | 105.78B | -4.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sawai Group Holdings | 253.14B |
| Towa Pharmaceutical | 196.67B |
| Kissei Pharmaceutical | 192.75B |
| Kaken Pharmaceutical | 158.10B |
| Mochida Pharmaceutical | 129.75B |
| Zeria Pharmaceutical | 92.88B |
| ASKA Pharmaceutical Holdings | 65.40B |
| Fuji Pharma | 61.40B |